SciVision Biotech Inc. (TPE:1786)
79.80
+0.60 (0.76%)
Jan 22, 2026, 1:35 PM CST
SciVision Biotech Market Cap
SciVision Biotech has a market cap or net worth of 5.79 billion as of January 21, 2026. Its market cap has decreased by -14.84% in one year.
Market Cap
5.79B
Enterprise Value
5.32B
Revenue
890.43M
Ranking
n/a
PE Ratio
35.83
Stock Price
79.80
Market Cap Chart
Since December 29, 2010, SciVision Biotech's market cap has increased from 1.23B to 5.79B, an increase of 371.29%. That is a compound annual growth rate of 10.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 5.79B | 10.47% |
| Dec 31, 2025 | 5.24B | -29.80% |
| Dec 31, 2024 | 7.47B | 42.10% |
| Dec 29, 2023 | 5.25B | 46.46% |
| Dec 30, 2022 | 3.59B | 9.27% |
| Dec 30, 2021 | 3.28B | -12.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 263.50B |
| PharmaEssentia | 217.10B |
| Lotus Pharmaceutical | 88.76B |
| Bora Pharmaceuticals Co., LTD. | 67.84B |
| Heron Neutron Medical | 67.13B |
| Oneness Biotech | 33.73B |
| Center Laboratories | 31.50B |
| Lumosa Therapeutics | 31.25B |